The primer
What Is DSIP? The Delta Sleep Inducing Peptide Explained
Nine amino acids, one slow brain-wave, and a mechanism science has never managed to name.
Start here
DSIP — the delta sleep inducing peptide — is one of the smallest messengers your body makes: a chain of just nine amino acids (the building blocks proteins are made from). It was first found in 1977, drawn from the blood of rabbits while they slept, and named for the slow, deep brain waves, called delta waves, that it seemed to deepen.
In plain terms, DSIP is a natural substance that may have something to do with deep sleep — but no one is certain how, or even how reliably. Scientists have never found its receptor, the molecular 'lock' a signaling molecule fits into, so its inner workings remain a genuine mystery. People today use the lab-made version hoping for deeper, more restful sleep, and results are all over the map: some sleep better, many notice nothing. It is not an approved medicine, and what follows is a tour of what is actually known, gaps and all.
What is DSIP peptide, exactly?
DSIP is a linear nonapeptide — a peptide nine amino acids long — with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu and a molecular weight near 849 daltons [1]. It occurs naturally in mammals, showing up in plasma, cerebrospinal fluid, and milk, frequently bound to a carrier protein [7]. A phosphorylated form, called DSIP-P, also appears in the literature and is reported as more potent in some assays [7].
The name is a description and a promise the molecule only half keeps. 'Delta' points to the slow delta brain-waves of deep sleep; 'sleep-inducing' is the effect its discoverers saw when they infused it into the brain [1]. It carries the International Nonproprietary Name Emideltide — the formal mark of a candidate drug substance — yet no Emideltide product was ever developed or approved [16].
Where it came from
The origin reads like a fable. In the 1970s, researchers electrically induced a sleep-like state in rabbits, collected blood from the cerebral veins of those sleeping animals, and from it isolated the peptide that deepened delta waves when given to others [1]. A molecule, in other words, distilled out of sleep and shown to carry a piece of it forward.
Through the 1980s and 1990s the peptide was studied widely — characterized in the lab and tested in small European pilot trials for insomnia, chronic pain, and alcohol and opiate withdrawal — while animal work probed its stress, growth-hormone, and neuroendocrine effects [16]. The deeper history is told on the DSIP effects page; the full DSIP half life and clearance story lives on the DSIP half life page.
Why it is called a riddle
Most signaling molecules are understood through their receptor — the lock the key turns. DSIP has none that anyone has found. Despite decades of work, no DSIP receptor, no DSIP gene, and no precursor protein has been conclusively isolated [3]. Its brain distribution sits in regions not obviously tied to sleep regulation, and its clearest sleep effects in later work came from synthetic analogs rather than the native peptide [3].
There is one more strangeness. DSIP shows a parabolic dose-response — its effect climbs and then falls as the dose rises, so an intermediate amount can outperform a larger one [7]. A molecule found inside sleep, present throughout the body, named for a brain-wave, and still, after forty years, a key without a lock. That is the riddle, stated plainly.
More than a sleep molecule
If DSIP only touched sleep, it would be simpler. Instead, the research has watched it reach into system after system — which is part of why it resists a single tidy explanation. In rats it raised growth hormone through a brain pathway that could be chemically blocked [9], and selectively lifted luteinizing hormone, a reproductive signal, while leaving its partner hormone FSH untouched [11]. In men, it briefly lowered the stress hormone ACTH without disturbing cortisol [4]. And in aging-research mice, a DSIP-containing preparation given in short monthly courses was reported to extend maximum lifespan and cut spontaneous tumors [5].
The catch is that the human versions of these findings often came up empty: in women, DSIP moved neither growth hormone nor prolactin [10]. So the honest one-line answer to 'what does DSIP do' is that it appears to nudge several systems in animals, does so unreliably in people, and works through a mechanism no one has pinned down. It is studied, today, mostly for sleep — but it has never been only a sleep molecule.
What is DSIP peptide not — and what it is not approved for
It helps to say plainly what DSIP is not. It is not an approved drug — not by the FDA, not by the European regulator, not by anyone, for any condition [3]. It carries a formal drug-substance name, Emideltide, but no Emideltide medicine was ever brought to market [16]. It is not a proven insomnia treatment; the best controlled human study called its sleep benefit modest and unlikely to be of major value on its own [18]. And it is not a reliable, predictable compound: a large share of people who try it report feeling nothing.
What it is, fairly stated, is a naturally occurring nine-amino-acid peptide with a fascinating origin, a genuinely unsolved mechanism, and a thin, mixed evidence base that this site reads in full on the DSIP research and DSIP effects pages. Holding both the curiosity and the caution at once is the only honest way to understand what the delta sleep inducing peptide is.